IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients

被引:63
作者
De La Barrera, S
Alemán, M
Musella, R
Schierloh, P
Pasquinelli, V
García, V
Abbate, E
Sasiain, MD
机构
[1] Acad Nacl Med Buenos Aires, Dept Inmunol, Inst Invest Hematol, RA-1425 Buenos Aires, DF, Argentina
[2] Hosp FJ Muniz, Div Tisioneumonol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, Lab Inmunogenet, Fac Med, Buenos Aires, DF, Argentina
关键词
IL-10; macrophages; coreceptors; cytotoxicity; tuberculosis;
D O I
10.1111/j.1365-2249.2004.02577.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of T cells requires both TCR-specific ligation and costimulation through accessory molecules during T cell priming. IFNgamma is a key cytokine responsible for macrophage activation during Mycobacterium tuberculosis (Mtb) infection while IL-10 is associated with suppression of cell mediated immunity in intracellular infection. In this paper we evaluated the role of IFNgamma and IL-10 on the function of cytotoxic T cells (CTL) and on the modulation of costimulatory molecules in healthy controls and patients with active tuberculosis (TB). gamma-irradiated-Mtb (i-Mtb) induced IL-10 production from CD14(+) cells from TB patients. Moreover, CD3(+) T cells of patients with advanced disease also produced IL-10 after i-Mtb stimulation. In healthy donors, IL-10 decreased the lytic activity of CD4(+) and CD8(+) T cells whereas it increased gammadelta-mediated cytotoxicity. Furthermore, we found that the presence of IL-10 induced a loss of the alternative processing pathways of antigen presentation along with a down-regulation of the expression of costimulatory molecule expression on monocytes and macrophages from healthy individuals. Conversely, neutralization of endogenous IL-10 or addition of IFNgamma to either effector or target cells from TB patients induced a strong lytic activity mediated by CD8(+) CTL together with an up-regulation of CD54 and CD86 expression on target cells. Moreover, we observed that macrophages from TB patients could use alternative pathways for i-Mtb presentation. Taken together, our results demonstrate that the presence of IL-10 during Mtb infection might contribute to mycobacteria persistence inside host macrophages through a mechanism that involved inhibition of MHC-restricted cytotoxicity against infected macrophages.
引用
收藏
页码:128 / 138
页数:11
相关论文
共 48 条
[1]   Augmentation of signal transducer and activation of transcription (STAT)6 and STAT3 expression in stimulated B and T cells [J].
Arinobu, Y ;
Sugimoto, R ;
Akaiwa, M ;
Arima, K ;
Otsuka, T ;
Hamasaki, N ;
Izuhara, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (02) :317-324
[2]   Processing of Mycobacterium tuberculosis bacilli by human monocytes for CD4+ αβ and γδ T cells:: Role of particulate antigen [J].
Balaji, KN ;
Boom, WH .
INFECTION AND IMMUNITY, 1998, 66 (01) :98-106
[3]   NEW PERSPECTIVES OF CD28-B7-MEDIATED T-CELL COSTIMULATION [J].
BLUESTONE, JA .
IMMUNITY, 1995, 2 (06) :555-559
[4]   IL-10-producing T cells suppress immune responses in anergic tuberculosis patients [J].
Boussiotis, VA ;
Tsai, EY ;
Yunis, EJ ;
Thim, S ;
Delgado, JC ;
Dascher, CC ;
Berezovskaya, A ;
Rousset, D ;
Reynes, JM ;
Goldfeld, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1317-1324
[5]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[6]  
Canaday DH, 1999, J IMMUNOL, V162, P372
[7]  
Compos-Neto A, 1998, J IMMUNOL, V160, P2037
[8]   Local immune responses correlate with presentation and outcome in tuberculosis [J].
Condos, R ;
Rom, WN ;
Liu, YM ;
Schluger, NW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :729-735
[9]   Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients [J].
Condos, R ;
Raju, B ;
Canova, A ;
Zhao, BY ;
Weiden, M ;
Rom, WN ;
Pine, R .
INFECTION AND IMMUNITY, 2003, 71 (04) :2058-2064
[10]  
Dagna L, 2002, EUR J IMMUNOL, V32, P2934, DOI 10.1002/1521-4141(2002010)32:10<2934::AID-IMMU2934>3.0.CO